ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020
The Role of Nuclear Medicine for COVID-19: Time to Act Now.
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Synthesis and in vitro evaluation of novel compounds and discovery of a promising iodine-125 radioligand for purinergic P2X7 receptor (P2X7R).Bioorganic & medicinal chemistry · 2025Article
- Mental health variables affecting Quality of Life (QOL) among healthcare workers during the COVID-19 pandemic in Jazan City, Saudi Arabia.Frontiers in psychology · 2024Article
- The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey.Scientific reports · 2023Article
- Molecular imaging as a tool for evaluation of COVID-19 sequelae - A review of literature.World journal of radiology · 2022Review
- The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.Frontiers in immunology · 2022Review
- FDG PET/CT imaging features and clinical utility in COVID-19.Clinical imaging · 2021Article
- P2RX7 at the Host-Pathogen Interface of Infectious Diseases.Microbiology and molecular biology reviews : MMBR · 2021Review
- Diagnostic, Prognostic, and Therapeutic Use of Radiopharmaceuticals in the Context of SARS-CoV-2.ACS pharmacology & translational science · 2021Review
- Mapping COVID-19 with nuclear imaging: from infection to functional sequelae.American journal of nuclear medicine and molecular imaging · 2021Article
- Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019.Frontiers in immunology · 2021Review
- Clinical features and radiological manifestations of COVID-19 disease.World journal of radiology · 2020Review
- A rationale for targeting the P2X7 receptor in Coronavirus disease 19.British journal of pharmacology · 2020Article
- Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases.International journal of molecular sciences · 2020Review
- Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020Article
- Post-COVID-19 New Normal for Nuclear Medicine Practice: An Australasian Perspective.Journal of nuclear medicine technology · 2020Review
- A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease.Nuclear medicine communications · 2020Article
- Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey.European journal of nuclear medicine and molecular imaging · 2020Article
- Mapping COVID-19 functional sequelae: the perspective of nuclear medicine.American journal of nuclear medicine and molecular imaging · 2020Review
- Clinical and laboratory characteristics of COVID-19 among adult patients admitted to the isolation centre at Abubakar Tafawa Balewa Teaching Hospital Bauchi, Northeast Nigeria.The Pan African medical journal · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.